- Home
- NSPR vs ICG Comparison
NSPR vs ICG Comparison
Compare NSPR & ICG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSPR
- ICG
- Stock Information
- Founded
- NSPR 2005
- ICG 2017
- Country
- NSPR United States
- ICG China
- Employees
- NSPR N/A
- ICG N/A
- Industry
- NSPR Medical/Dental Instruments
- ICG Semiconductors
- Sector
- NSPR Health Care
- ICG Technology
- Exchange
- NSPR Nasdaq
- ICG Nasdaq
- Market Cap
- NSPR 99.7M
- ICG 102.7M
- IPO Year
- NSPR N/A
- ICG 2023
- Fundamental
- Price
- NSPR $2.42
- ICG $1.79
- Analyst Decision
- NSPR Strong Buy
- ICG Strong Buy
- Analyst Count
- NSPR 2
- ICG 1
- Target Price
- NSPR $4.50
- ICG $7.50
- AVG Volume (30 Days)
- NSPR 119.2K
- ICG 121.1K
- Earning Date
- NSPR 11-11-2025
- ICG 11-19-2025
- Dividend Yield
- NSPR N/A
- ICG N/A
- EPS Growth
- NSPR N/A
- ICG N/A
- EPS
- NSPR N/A
- ICG 0.05
- Revenue
- NSPR $7,066,000.00
- ICG $43,282,895.00
- Revenue This Year
- NSPR $7.48
- ICG N/A
- Revenue Next Year
- NSPR $104.39
- ICG $64.55
- P/E Ratio
- NSPR N/A
- ICG $38.60
- Revenue Growth
- NSPR 7.60
- ICG 63.55
- 52 Week Low
- NSPR $1.99
- ICG $1.19
- 52 Week High
- NSPR $3.80
- ICG $12.04
- Technical
- Relative Strength Index (RSI)
- NSPR 50.48
- ICG 43.88
- Support Level
- NSPR $2.38
- ICG $1.63
- Resistance Level
- NSPR $2.57
- ICG $1.98
- Average True Range (ATR)
- NSPR 0.07
- ICG 0.10
- MACD
- NSPR 0.01
- ICG 0.03
- Stochastic Oscillator
- NSPR 36.51
- ICG 42.86
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About ICG Intchains Group Limited
Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.